✦ LIBER ✦

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

✍ Scribed by Christopher P Cannon; Robert A Harrington; Stefan James; Diego Ardissino; Richard C Becker; Håkan Emanuelsson; Steen Husted; Hugo Katus; Matyas Keltai; Nardev S Khurmi; Frederic Kontny; Basil S Lewis; Philippe Gabriel Steg; Robert F Storey; Daniel Wojdyla; Lars Wallentin

Book ID: 117306038
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 167 KB
Volume: 375
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(09)62191-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV81 Cost-Effectiveness of Ticagrelor V

PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian Analysis

✍ N. Mittmann; B. Chan; S.J. Seung; A. Liovas; E. Cohen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Ticagrelor Versus Clopidogrel in Patient

Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis

✍ Steg, P. G.; James, S.; Harrington, R. A.; Ardissino, D.; Becker, R. C.; Cannon, 📂 Article 📅 2010 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 985 KB

REDUCTION IN PULMONARY ADVERSE EVENTS AN

REDUCTION IN PULMONARY ADVERSE EVENTS AND ASSOCIATED SEPSIS AND MORTALITY IN ACUTE CORONARY SYNDROME PATIENTS TREATED WITH TICAGRELOR COMPARED TO CLOPIDOGREL: A POST HOC ANALYSIS OF THE PLATO STUDY

✍ Robert F. Storey; Philippe Steg; Stefan James; Steen Husted; Christopher Cannon; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Design and rationale of the Treatment of

Design and rationale of the Treatment of Acute Coronary Syndromes with Otamixaban trial: A double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non–ST-segment elevation acute coronary syndromes with a planned early invasive strategy

✍ Philippe Gabriel Steg; Shamir R. Mehta; Charles V. Pollack Jr.; Christoph Bode; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 398 KB

Randomized Double-Blind Assessment of th

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease: The ONSET/OFFSET Study

✍ Gurbel, P. A.; Bliden, K. P.; Butler, K.; Tantry, U. S.; Gesheff, T.; Wei, C.; T 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 563 KB

Otamixaban for the treatment of patients

Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial

✍ Marc S Sabatine; Elliott M Antman; Petr Widimsky; Iftikhar O Ebrahim; Robert G K 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 247 KB